Perfusion Index Changes in Cardiovascular Autonom Neuropathia Type-2 Dm Whit Spinal Anesthesia

• Conditions: Anesthesia; Adverse Effect
• Interventions: Device: perfusion index monitor; Diagnostic Test: ewing test

• Registration Number: NCT03869775
• Lead Sponsor: Erzincan University

Brief Summary

Cardiovascular autonomic neuropathy in diabetic patients, hypertension, sympathovagal imbalance, orthostatic hypotension, painless myocardial infarction, ischemia, left ventricular dysfunction, cardiac sympathetic and parasympathetic innervation disturbances, qt interval prolongation and sudden deaths observed. The purpose of this study is to evaluate the relationship between cardiovascular autonomic neuropathy and perfusion index in spinal anesthesia

Detailed Description

Cardiovascular autonomic neuropathy in diabetic patients, hypertension, sympathovagal imbalance, orthostatic hypotension, painless myocardial infarction, ischemia, left ventricular dysfunction, cardiac sympathetic and parasympathetic innervation disturbances, qt interval prolongation and sudden deaths observed. The purpose of this study is to evaluate the relationship between cardiovascular autonomic neuropathy and perfusion index in spinal anesthesia

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study Start: 2017-12-01
• Status Verified: 2019-03
• Study First Submitted: 2019-03-06
• Study First Submitted QC: 2019-03-07
• Last Update Submitted: 2019-03-10
• Study First Posted: 2019-03-11
• Last Update Posted: 2019-03-12
• Primary Completion: 2020-12-01
• Study Completion: 2020-12-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 240

Inclusion Criteria

• the patient will be operated with spinal anesthesia
• over 18 years
• no additional disease and only DM

Read More

Exclusion Criteria

• patients with additional disease
• patients under 18 years of age
• patients contraindicated in spinal anesthesia

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
control group	perfusion index monitor	no additional disease
working group-2	ewing test	additional disease only DM and pozitif cardıovascular autonomous neuropathıa
working group-1	perfusion index monitor	additional disease only DM and no cardıovascular autonomous neuropathıa
working group-2	perfusion index monitor	additional disease only DM and pozitif cardıovascular autonomous neuropathıa
working group-1	ewing test	additional disease only DM and no cardıovascular autonomous neuropathıa

Primary Outcome Measures

Name	Time	Method
Perfusion index change	Day 1	Perfusion index change in spinal anesthesia related cardiovascular autonom neuropatia

Trial Locations

Locations (1)

Erzincanu; 🇹🇷 Erzincan, Merkez, Turkey